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Abstract
Lymphoid tissue-inducer cells are hematopoietic cells essential for the organogenesis of several
lymphoid structures during both fetal and adult life, whereas natural killer cells are key effector
lymphocytes of the innate immune system. A series of recent reports has identified RORgt
+NKp46
+
interleukin-22-producing cells in gut and tonsils that share features with both lymphoid tissue-inducer
cells and natural killer cells and that may be involved in mucosal immunity and homeostasis.
Introduction and context
The internal surfaces of the body are covered by distinct
types of mucosal epithelia. These tissues constitute the
first physical and immunological defense against various
environmental insults and enclose local immune sys-
tems characterized by tissue-specific organization and
complexity [1]. Gut-associated lymphoid tissues
(GALTs) include lymphoid structures harboring different
degrees of organization, such as mesenteric lymph
nodes, Peyer’s patches, cryptopatches, and isolated
lymphoid follicles (ILFs), as well as of a network of
immune cells scattered in both epithelium and under-
lying lamina propria connective tissue [2]. Tonsils
belong to the nasopharynx-associated lymphoid tissue
(NALT), which shares functional similarities with GALT
but differs in its ontogenetic program [3].
Lymphoid tissue-inducer (LTi) cells are hematopoietic
cells required for lymphoid organogenesis during both
fetal and adult life [4,5]. LTi cell interaction with stromal
organizer cells via lymphotoxin beta (LTb) and tumor
necrosis factor signals induces chemokine secretion and
adhesion molecule expression upregulation, both crucial
events for LTi cell and mature lymphocyte recruitment
and subsequent lymphoid tissue organization [4]. In
mouse embryo, LTi cell development and function are
dependent on the expression of transcription factors
such as retinoic acid-related orphan receptor gamma t
(RORgt) and Id2 [6,7] as well as of interleukin (IL)-7Ra
receptor and LTa1b2 cytokine [4]. In the adult mouse, the
LTi cells are found mainly within cryptopatch and ILF
gut lymphoid structures, in close contact with dendritic
cells [8], as well as in the spleen [9–11].
Natural killer (NK) cells are lymphocytes belonging to
the innate immune system that are able to exert two
major effector functions, cytotoxicity and cytokine
secretion [12]. Therefore, NK cells can limit the spreading
of microbial infections as well as of cells undergoing
several kinds of cellular stress, and participate in the
orchestration of adaptive immune responses. NK cells
are ubiquitously expressed in both lymphoid and non-
lymphoid organs, where they harbor distinct phenotypic
and functional properties, depending on tissue locations
[13–15]. An NK cell subset resident in mucosal tissues,
such as human tonsils, has been documented [16].
However, the presence and the function of NK cells in
GALT have been poorly investigated [17–19].
Major recent advances
By using the NK cell marker NKp46 [20], which is the
most selective NK cell marker described so far in humans
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new population of RORgt
+NKp46
+ IL-22-producing cells
in the adult mouse gut [22–25]. Within the mouse gut,
RORgt
+NKp46
+ cells have been identified in at least
three different locations. First, RORgt
+NKp46
+ cells are
detectable in variable proportions among RORgt
+ cells
constituting cryptopatches (Figure 1, right panel)
[22,23]. Second, a significant fraction of NKp46
+ cells
present in the lamina propria also express RORgt, thus
revealing the existence of two distinct RORgt
+NKp46
+
and RORgt
−NKp46
+ cell subpopulations (Figure 1, left
panel) [22–24]. As described below, these two subsets
harbor distinct developmental programs as well as
phenotypic and functional properties. Finally,
RORgt
+NKp46
+ and RORgt
−NKp46
+ cells are also
found within Peyer’s patches, in particular in subepithe-
lial dome and interfollicular areas [22,25].
Interestingly, RORgt
+NKp46
+ and RORgt
−NKp46
+ cell
subsets have distinct ontogenetic programs. While
RORgt
+NKp46
+ cell development requires both RORgt
expression and exposure to commensal flora [22–24],
RORgt
−NKp46
+ cell subset generation is dependent
upon IL-2/IL-15 signaling [23,24]. RORgt
+NKp46
+ cells
thus share some developmental requisites with LTi cells,
whereas RORgt
−NKp46
+ cell subset ontogeny appears
t ob er e l a t e dt ot h a to fc o n v e n t i o n a lN Kc e l l s .
RORgt
−NKp46
+ cells express the mouse NK cell marker
NK1.1 and contain perforin and interferon-gamma
(IFN-g), though at lower levels than in lymphoid NK
cells. In contrast, RORgt
+NKp46
+ cells express low
amounts of the NK cell marker NK1.1, are devoid of
messages encoding perforin and IFN-g, but are equipped
to secrete IL-22 [22–25]. IL-22, an IL-10 family member,
induces epithelial secretion of various antimicrobial
products, such as defensins and S100 calcium-binding
proteins, and of various molecules involved in epithelial
tissue proliferation and homeostasis, thus contributing
to greater epithelial resistance to injury after microbial
infection of the lung and the gut [26]. Consistent
with this protective function of IL-22, mucosal
RORgt
+NKp46
+ cells appear to play a critical role in
the defense against the extracellular enteric pathogen
Citrobacter rodentium [24,25]. Furthermore, IL-22-expres-
sing NK-like cells have been recently shown to contribute
to protection from experimental inflammatory bowel
disease [27].
A subset of CD56
+NKp44
+ cells represents the human
functional equivalent of the mouse gut RORgt
+NKp46
+
population. Indeed, these cells reside within human
tonsils and intestines, contain mRNA encoding human
RORgt, and constitutively produce IL-22, but not IL-17A
[25]. Like mouse RORgt
+NKp46
+ cells, these human
IL-22-producing cells express some NK cell-associated
markers, including NKp46 (H Spits, personal commu-
nication), yet lack perforin and granzyme and are
unable to produce IFN-g. The human mucosal
RORgt
+CD56
+NKp44
+ cell subset is possibly the progeny
of newly discovered human LTi cells [28]. Indeed, the
phenotype of RORgt
+CD56
+ cells generated in vitro from
human fetal LTi cells [28] resembles the mucosal RORgt
+
cells found in human tonsil and intestines [25].
However, unlike adult cell populations found postna-
tally, fetal human LTi cells and RORgt
+NKp46
+ cells
produce only very low amounts of IL-22 message yet
constitutively express IL-17A [28]. A switch from IL-17 to
IL-22 expression has also been reported in mouse LTi
cells from birth to adult life [29].
Future directions
Several questions regarding this novel mucosal
RORgt
+NKp46
+ cell subset remain unanswered. First,
what are the stimuli that promote the expression of NK
cell receptors on these cells? In particular, what is the
potential role of commensal flora exposure in inducing
the expression of NK cell receptors and their respective
ligands? Second, the features shared by both LTi and
NK cells in mouse RORgt
+NKp46
+ and human
Figure 1. Immunofluorescence histology of mouse gut intestine
Immunofluorescence histology of frozen sections of mouse gut intestine
stained with anti-NKp46 (green), anti-RORgt (red), and anti-CD3 (blue).
Nuclei were counterstained with Sytox (grey). The left panel shows small
intestini villi; the right panel shows cryptopatches. Magnification ×40.
RORgt, retinoic acid-related orphan receptor gamma t.
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+CD56
+NKp44
+ cells call for a closer look into
their developmental relationships. Finally, the ability to
secrete IL-22 highlights the potential contribution of this
new cell type to mucosal tissue protection and home-
ostasis (for example, epithelium repair) upon diverse
environmental insults and paves the way for the
development of novel strategies to target these functions.
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